Both the Immunosuppressant SR31747 and the Antiestrogen Tamoxifen Bind to an Emopamil-Insensitive Site of Mammalian Δ8-Δ7 Sterol Isomerase

SR31747 is a novel agent that elicits immunosuppressive and anti-inflammatory effects. This drug was shown to inhibit Δ8-Δ7 sterol isomerase in yeast. To test whether this enzyme could also be an SR31747 target in mammals, the binding, antiproliferative and sterol biosynthesis inhibitory properties of various drugs were studied in recombinant sterol isomerase-producing yeast cells. Our results clearly show that SR31747 is a high affinity ligand of recombinant mammalian sterol isomerase ( K d = 1 nM). Tridemorph, a sterol biosynthesis inhibitor that is widely used in agriculture as an antifungal agent, is also a powerful inhibitor of murine and human sterol isomerases (IC50 value in the nanomolar range). Some drugs, like cis -flupentixol, trifluoperazine, 7-ketocholestanol and tamoxifen, inhibit SR31747 binding only with the mammalian enzymes, whereas other drugs, like haloperidol and fenpropimorph, are much more effective with the yeast enzyme than with the mammalian ones. Emopamil, a high affinity ligand of human sterol isomerase, is inefficient in inhibiting SR31747 binding to its mammalian target, suggesting that the SR31747 and emopamil binding sites on mammalian sterol isomerase do not overlap. In contrast, SR31747 binding inhibition by tamoxifen is very efficient and competitive (IC50 value in the nanomolar range), indicating that mammalian sterol isomerase contains a so-called antiestrogen binding site. Tamoxifen is found to selectively inhibit sterol biosynthesis at the sterol isomerase step in the cells that are producing the mammalian enzyme in place of their own sterol isomerase. Finally, we also show that tridemorph, a sterol biosynthesis inhibitor widely used in agriculture as an antifungal agent, is not selective of yeast Δ8-Δ7 sterol isomerase but is also highly efficient against murine Δ8-Δ7 sterol isomerase or human Δ8-Δ7 sterol isomerase. This observation contrasts with our already published results showing that fenpropimorph, another sterol isomerase inhibitor used in agriculture, is only poorly efficient against the mammalian enzymes.

[1]  H. Glossmann,et al.  The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. , 1997, Trends in pharmacological sciences.

[2]  P Chambon,et al.  Estradiol-inducible squelching and cell growth arrest by a chimeric VP16-estrogen receptor expressed in Saccharomyces cerevisiae: suppression by an allele of PDR1 , 1993, Molecular and cellular biology.

[3]  M. Kaghad,et al.  Emopamil-binding Protein, a Mammalian Protein That Binds a Series of Structurally Diverse Neuroprotective Agents, Exhibits Δ8-Δ7 Sterol Isomerase Activity in Yeast* , 1996, The Journal of Biological Chemistry.

[4]  H. Glossmann,et al.  Yeast sterol C8-C7 isomerase: identification and characterization of a high-affinity binding site for enzyme inhibitors. , 1996, Biochemistry.

[5]  H. Li,et al.  Role of Multidrug Resistance P-glycoproteins in Cholesterol Biosynthesis (*) , 1996, The Journal of Biological Chemistry.

[6]  P. Casellas,et al.  Immunopharmacological profile of SR 31747: In vitro and in vivo studies on humoral and cellular responses , 1994, Journal of Neuroimmunology.

[7]  P. Casellas,et al.  In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747. , 1995, The Journal of pharmacology and experimental therapeutics.

[8]  P. Casellas,et al.  The sigma ligand SR 31747 prevents the development of acute graft-versus-host disease in mice by blocking IFN-gamma and GM-CSF mRNA expression. , 1995, International journal of immunopharmacology.

[9]  J. Metherall,et al.  Progesterone Inhibits Cholesterol Biosynthesis in Cultured Cells , 1996, The Journal of Biological Chemistry.

[10]  J. Faye,et al.  Antiestrogen specific, high affinity saturable binding sites in rat uterine cytosol. , 1980, Biochemical and biophysical research communications.

[11]  P. Casellas,et al.  Enhancement of endotoxin‐induced interleukin‐10 production by SR 31747A, a sigma ligand , 1995, European journal of immunology.

[12]  E. Mercer,et al.  Inhibition of sterol Δ8 → Δ7-isomerase and Δ14-reductase by fenpropimorph tridemorph and fenpropidin in cell-free enzyme systems from Saccharomyces cerevisiae , 1987 .

[13]  S. Ng,et al.  Synthesis of 2-(p-chlorobenzyl)-3-aryl-6-methoxybenzofurans as selective ligands for antiestrogen-binding sites. Effects on cell proliferation and cholesterol synthesis. , 1992, Journal of medicinal chemistry.

[14]  J. Leysen,et al.  Neuroprotective sigma ligands interfere with the glutamate‐activated NOS pathway in hippocampal cell culture , 1995, Synapse.

[15]  M. Kołaczkowski,et al.  Anticancer Drugs, Ionophoric Peptides, and Steroids as Substrates of the Yeast Multidrug Transporter Pdr5p* , 1996, The Journal of Biological Chemistry.

[16]  M. Kaghad,et al.  The immunosuppressant SR 31747 blocks cell proliferation by inhibiting a steroid isomerase in Saccharomyces cerevisiae , 1996, Molecular and cellular biology.

[17]  S. Galiègue,et al.  Purification and Characterization of the Human SR 31747A-binding Protein , 1997, The Journal of Biological Chemistry.

[18]  B. Descomps,et al.  Role of estrogen receptors and antiestrogen binding sites in an early effect of antiestrogens, the inhibition of cholesterol biosynthesis. , 1988, Journal of steroid biochemistry.

[19]  P. Casellas,et al.  Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747 , 1994, Journal of Neuroimmunology.

[20]  F. Schuber,et al.  Inhibition by the fungicide fenpropimorph of cholesterol biosynthesis in 3T3 fibroblasts. , 1988, The Biochemical journal.

[21]  L. Murphy,et al.  High-affinity anti-oestrogen binding site distinct from the oestrogen receptor , 1980, Nature.

[22]  Gerald R. Fink,et al.  Guide to yeast genetics and molecular biology , 1993 .

[23]  F. Karst,et al.  In vivo effects of fenpropimorph on the yeast Saccharomyces cerevisiae and determination of the molecular basis of the antifungal property , 1990, Antimicrobial Agents and Chemotherapy.

[24]  L. Kangas,et al.  Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  B. Katzenellenbogen,et al.  Antiestrogen-binding sites distinct from the estrogen receptor: subecellular localization, ligand specificity, and distribution in tissues of the rat. , 1983, Endocrinology.

[26]  H. Glossmann,et al.  Phenylalkylamine Ca2+ Antagonist Binding Protein , 1995, The Journal of Biological Chemistry.